82 related articles for article (PubMed ID: 16364599)
1. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid.
Yoshida M; Hamada T; Amagai M; Hashimoto K; Uehara R; Yamaguchi K; Imamura K; Okamoto E; Yasumoto S; Hashimoto T
J Dermatol Sci; 2006 Jan; 41(1):21-30. PubMed ID: 16364599
[TBL] [Abstract][Full Text] [Related]
2. Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity.
Emtenani S; Linnemann BE; Recke A; von Georg A; Goletz S; Schmidt E; van Beek N
J Dermatol Sci; 2024 May; 114(2):64-70. PubMed ID: 38582700
[TBL] [Abstract][Full Text] [Related]
3. Expression of Serum Anti-BP180/230 Antibodies in Bullous Pemphigoid Patients Combined with Nervous System Diseases and Relevant Factor Analysis.
Liu G; Li B; Zhao Z; Qin L; Zhao Y; Fang S
J Coll Physicians Surg Pak; 2024 Feb; 34(2):141-145. PubMed ID: 38342861
[TBL] [Abstract][Full Text] [Related]
4. Factors associated with the activity and severity of bullous pemphigoid: a review.
Liu Y; Wang Y; Chen X; Jin H; Li L
Ann Med; 2020; 52(3-4):55-62. PubMed ID: 32163298
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of ELISA BP180 and BP230 Autoantibodies in Blister Fluid and Serum in the Diagnosis of Bullous Pemphigoid.
Nagarajan H; Mahadevan K; Rai R; Boppe A
Indian J Dermatol; 2023; 68(1):122. PubMed ID: 37151247
[TBL] [Abstract][Full Text] [Related]
6. Accurate diagnosis of bullous pemphigoid requires multiple health care visits.
Leisti P; Pankakoski A; Jokelainen J; Varpuluoma O; Huilaja L; Panelius J; Tasanen K
Front Immunol; 2023; 14():1281302. PubMed ID: 38090583
[TBL] [Abstract][Full Text] [Related]
7. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy.
van Beek N; Rentzsch K; Probst C; Komorowski L; Kasperkiewicz M; Fechner K; Bloecker IM; Zillikens D; Stöcker W; Schmidt E
Orphanet J Rare Dis; 2012 Aug; 7():49. PubMed ID: 22876746
[TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson's disease is more relevant to bullous pemphigoid.
Bartkiewicz P; Gornowicz-Porowska J; Pietkiewicz PP; Świrkowicz A; Bowszyc-Dmochowska M; Dmochowski M
Postepy Dermatol Alergol; 2017 Feb; 34(1):42-46. PubMed ID: 28261030
[TBL] [Abstract][Full Text] [Related]
9. Post-Surgical Anti-BP230 Bullous Pemphigoid: A Rare Cause of Non-Healing Wound.
Pipitò C; Baffa ME; Maglie R; Senatore S; Antiga E
Dermatol Pract Concept; 2024 Jan; 14(1):. PubMed ID: 38364416
[No Abstract] [Full Text] [Related]
10. Diagnostic Techniques in Autoimmune Blistering Diseases.
Mee JB
Br J Biomed Sci; 2023; 80():11809. PubMed ID: 38074463
[TBL] [Abstract][Full Text] [Related]
11. Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
Chen HC; Wang CW; Toh WH; Lee HE; Chung WH; Chen CB
Clin Rev Allergy Immunol; 2023 Dec; 65(3):331-353. PubMed ID: 37897588
[TBL] [Abstract][Full Text] [Related]
12. Researching trends in pemphigoid diseases: A bibliometric study of the top 100 most cited publications.
Huang SC; Chiu TM; Lee CY; Chang HC; Wu WJ; Gau SY
Front Med (Lausanne); 2022; 9():1088083. PubMed ID: 36698818
[TBL] [Abstract][Full Text] [Related]
13. Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders.
Opelka B; Schmidt E; Goletz S
Front Immunol; 2022; 13():948108. PubMed ID: 36032160
[TBL] [Abstract][Full Text] [Related]
14. The significance of preclinical anti-BP180 autoantibodies.
Mai Y; Izumi K; Mai S; Ujiie H
Front Immunol; 2022; 13():963401. PubMed ID: 36003369
[TBL] [Abstract][Full Text] [Related]
15. Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid.
Cole C; Borradori L; Amber KT
Antibodies (Basel); 2022 Jun; 11(3):. PubMed ID: 35892704
[TBL] [Abstract][Full Text] [Related]
16. Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases.
Heckler I; Hong M; Amart Sinha A; Venkataraman I
Dermatol Pract Concept; 2022 May; 12(2):e2022116. PubMed ID: 35646449
[TBL] [Abstract][Full Text] [Related]
17. Pemphigus and Pemphigoid: From Disease Mechanisms to Druggable Pathways.
Ellebrecht CT; Maseda D; Payne AS
J Invest Dermatol; 2022 Mar; 142(3 Pt B):907-914. PubMed ID: 34756581
[TBL] [Abstract][Full Text] [Related]
18. Resolution in bullous pemphigoid.
Sadik CD; Schmidt E
Semin Immunopathol; 2019 Nov; 41(6):645-654. PubMed ID: 31732776
[TBL] [Abstract][Full Text] [Related]
19. Serological Diagnosis of Autoimmune Bullous Skin Diseases.
Saschenbrecker S; Karl I; Komorowski L; Probst C; Dähnrich C; Fechner K; Stöcker W; Schlumberger W
Front Immunol; 2019; 10():1974. PubMed ID: 31552014
[TBL] [Abstract][Full Text] [Related]
20. Complement-Activating Capacity of Autoantibodies Correlates With Disease Activity in Bullous Pemphigoid Patients.
Chiorean RM; Baican A; Mustafa MB; Lischka A; Leucuta DC; Feldrihan V; Hertl M; Sitaru C
Front Immunol; 2018; 9():2687. PubMed ID: 30524436
[No Abstract] [Full Text] [Related]
[Next] [New Search]
